108 related articles for article (PubMed ID: 20210579)
1. Company profile: Biocompatibles International plc: local drug delivery for targeted therapies.
Coppen D
Regen Med; 2010 Mar; 5(2):189-95. PubMed ID: 20210579
[No Abstract] [Full Text] [Related]
2. The new materials technology of drug delivery.
Williams D
Med Device Technol; 2001 Oct; 12(8):10-3. PubMed ID: 12938542
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery: the heart of the matter.
Putnam D
Nat Mater; 2008 Nov; 7(11):836-7. PubMed ID: 18955993
[No Abstract] [Full Text] [Related]
4. What makes a good drug target?
Gashaw I; Ellinghaus P; Sommer A; Asadullah K
Drug Discov Today; 2011 Dec; 16(23-24):1037-43. PubMed ID: 21945861
[TBL] [Abstract][Full Text] [Related]
5. Dendrimers and dendritic polymers in drug delivery.
Gillies ER; Fréchet JM
Drug Discov Today; 2005 Jan; 10(1):35-43. PubMed ID: 15676297
[TBL] [Abstract][Full Text] [Related]
6. Historical perspective on advanced drug delivery: how engineering design and mathematical modeling helped the field mature.
Peppas NA
Adv Drug Deliv Rev; 2013 Jan; 65(1):5-9. PubMed ID: 23032270
[TBL] [Abstract][Full Text] [Related]
7. [Types of non-viral delivery systems of small interfering RNA].
Glebova KV; Marakhonov AV; Baranova AV; Skoblov MIu
Mol Biol (Mosk); 2012; 46(3):387-401. PubMed ID: 22888629
[TBL] [Abstract][Full Text] [Related]
8. Company profile: Athersys.
Van Bokkelen G
Regen Med; 2011 Jan; 6(1):39-43. PubMed ID: 21175285
[TBL] [Abstract][Full Text] [Related]
9. A dose of reality for rational therapies.
Nat Biotechnol; 2005 Mar; 23(3):267. PubMed ID: 15765066
[No Abstract] [Full Text] [Related]
10. The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspective.
Perry WL; Weitzman A
Clin Adv Hematol Oncol; 2005 Mar; 3(3):199-202, 237-8. PubMed ID: 16166991
[TBL] [Abstract][Full Text] [Related]
11. The right time and the right place: the concepts and concerns of drug delivery systems.
Williams D
Med Device Technol; 1998 Mar; 9(2):10-2, 16. PubMed ID: 10186972
[TBL] [Abstract][Full Text] [Related]
12. Advances in recombinant polymers for delivery of bioactive agents.
Ghandehari H; Hatefi A
Adv Drug Deliv Rev; 2010 Dec; 62(15):1403. PubMed ID: 20667495
[No Abstract] [Full Text] [Related]
13. Combining local drug delivery and implantable medical devices.
Anderson AB
Med Device Technol; 2003 Sep; 14(7):16-9. PubMed ID: 14528808
[TBL] [Abstract][Full Text] [Related]
14. A biodegradable and biocompatible drug-delivery system based on polyoxalate microparticles.
Lee E; Kim S; Seong K; Park H; Seo H; Khang G; Lee D
J Biomater Sci Polym Ed; 2011; 22(13):1683-94. PubMed ID: 20699060
[TBL] [Abstract][Full Text] [Related]
15. The influence of chain microstructure on hydrolytic degradation of glycolide/lactide copolymers used in drug delivery systems.
Maciejowska J; Kasperczyk J; Dobrzyñski P; Bero M
J Control Release; 2006 Nov; 116(2):e6-8. PubMed ID: 17718972
[No Abstract] [Full Text] [Related]
16. Material vectors for gene delivery.
Williams D
Med Device Technol; 2004 May; 15(4):8-10. PubMed ID: 15303554
[TBL] [Abstract][Full Text] [Related]
17. Patient-friendly bioerodible drug delivery systems.
Heller J
J Control Release; 2009 Jan; 133(2):88-9. PubMed ID: 18930773
[No Abstract] [Full Text] [Related]
18. Delivering the goods.
Phys Chem Chem Phys; 2007 Mar; 9(11):C23. PubMed ID: 17447329
[No Abstract] [Full Text] [Related]
19. Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury.
Wang Y; Cooke MJ; Morshead CM; Shoichet MS
Biomaterials; 2012 Mar; 33(9):2681-92. PubMed ID: 22217804
[TBL] [Abstract][Full Text] [Related]
20. Methacrylamide-oligolactates as building blocks for targeted biodegradable polymeric micelles to deliver photosensitizers.
Rijcken CJ; Leemhuis M; Hofman JW; van Zeeland F; Ramzi A; van Nostrum CF; Hennink WE
J Control Release; 2006 Nov; 116(2):e10-2. PubMed ID: 17718937
[No Abstract] [Full Text] [Related]
[Next] [New Search]
